| Literature DB >> 2265140 |
M E van der Burg1, F B Lammes, J Verweij.
Abstract
The role of CA 125 determination in diagnosing progression of ovarian cancer was evaluated in 98 patients of whom forty-nine had progressive disease. An elevated CA 125 level at the time of progression was found in 36 (73%) patients. In 31 (63%) patients CA 125 increase preceded clinical progression for a median time lag of 4.5 months (range 0.5-29.5 months). The combination of serum CA 125, gynecological and general physical examination detected progression in 45 (92%) patients. The additional contribution of second-look surgery, CTscan, chest X-ray and routine laboratory tests was minimal.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2265140 DOI： 10.1093/oxfordjournals.annonc.a057754
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976